These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26713839)

  • 41. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.
    Rasmussen MH; Janukonyté J; Klose M; Marina D; Tanvig M; Nielsen LF; Höybye C; Andersen M; Feldt-Rasmussen U; Christiansen JS
    J Clin Endocrinol Metab; 2016 Mar; 101(3):988-98. PubMed ID: 26727076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH.
    Hayakawa M; Shimazaki Y; Tsushima T; Kato Y; Takano K; Chihara K; Shimatsu A; Irie M
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1562-71. PubMed ID: 15070913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.
    Marchisotti FG; Jorge AA; Montenegro LR; Berger K; de Carvalho LR; Mendonca BB; Arnhold IJ
    Growth Horm IGF Res; 2009 Apr; 19(2):179-86. PubMed ID: 19036620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV-1106, a Long-Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects.
    Cohen-Barak O; Barkay H; Rasamoelisolo M; Butler K; Yamada K; Bassan M; Yoon E; Spiegelstein O
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):331-342. PubMed ID: 27489211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo characterization of sustained-release formulations of human growth hormone.
    Lee HJ; Riley G; Johnson O; Cleland JL; Kim N; Charnis M; Bailey L; Duenas E; Shahzamani A; Marian M; Jones AJ; Putney SD
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1431-9. PubMed ID: 9190880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
    J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
    Kemp SF; Fielder PJ; Attie KM; Blethen SL; Reiter EO; Ford KM; Marian M; Dao LN; Lee HJ; Saenger P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3234-40. PubMed ID: 15240597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
    Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
    Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel long-acting crystal formulation of human growth hormone.
    Govardhan C; Khalaf N; Jung CW; Simeone B; Higbie A; Qu S; Chemmalil L; Pechenov S; Basu SK; Margolin AL
    Pharm Res; 2005 Sep; 22(9):1461-70. PubMed ID: 16132358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
    Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
    Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.
    Clark RG; Mortensen DL; Carlsson LM; Spencer SA; McKay P; Mulkerrin M; Moore J; Cunningham BC
    Endocrinology; 1996 Oct; 137(10):4308-15. PubMed ID: 8828490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro characterization of MOD-5014, a novel long-acting carboxy-terminal peptide (CTP)-modified activated FVII.
    Bar-Ilan A; Livnat T; Hoffmann M; Binder L; Zakar M; Guy R; Felikman Y; Moschcovich L; Shenkman B; Monroe D; Hershkovitz O; Kenet G; Hart G
    Haemophilia; 2018 May; 24(3):477-486. PubMed ID: 29537116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age.
    Huang Y; Du M; Zhuang S; Shen Z; Li Y
    Horm Res Paediatr; 2010; 74(2):106-13. PubMed ID: 20395663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
    Thissen JP; Triest S; Underwood LE; Maes M; Ketelslegers JM
    Endocrinology; 1990 Feb; 126(2):908-13. PubMed ID: 2298175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
    Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH
    Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel long-acting GH preparations.
    Doknic M; Stojanovic M; Popovic V
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):206-12. PubMed ID: 25581986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.